Becton Dickinson (BDX) Liabilities and Shareholders Equity (2009 - 2026)

Becton Dickinson's (BDX) quarterly Liabilities and Shareholders Equity came in at $50.8 billion in Q1 2026, down 6.67% year-on-year from $54.5 billion in Q1 2025, and down 7.31% on a QoQ basis from $54.8 billion in Q4 2025.

Becton Dickinson (BDX) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends

Becton Dickinson (BDX) has 18 years of Liabilities and Shareholders Equity data on file, last reported at $50.8 billion in Q1 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 6.67% year-over-year to $50.8 billion in Q1 2026; TTM through Mar 2026 was $215.9 billion, a 2.75% decrease from a year earlier, with the FY2025 full-year figure at $55.3 billion, down 3.42% from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 stood at $50.8 billion, down from $54.8 billion in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for BDX reached as high as $57.3 billion in Q3 2024 and fell as low as $50.8 billion in Q1 2026.
  • Historically, Liabilities and Shareholders Equity has averaged $54.0 billion across 5 years, with a median of $54.4 billion in 2023.
  • Across the five-year window, Liabilities and Shareholders Equity advanced 8.54% in 2024 and slipped 6.67% in 2026, its largest moves.
  • Year by year, Liabilities and Shareholders Equity stood at $53.1 billion in 2022, then decreased by 1.61% to $52.3 billion in 2023, then increased by 4.57% to $54.7 billion in 2024, then advanced by 0.32% to $54.8 billion in 2025, then dropped by 7.31% to $50.8 billion in 2026.
  • Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $50.8 billion in Q1 2026, $54.8 billion in Q4 2025, and $55.3 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn 31.62 Bn
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn 20.88 Bn
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn 50.83 Bn
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn 39.01 Bn
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn 8.78 Bn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn 4.08 Bn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn 12.48 Bn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn 14.10 Bn
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn 6.31 Bn
10 Baxter International 11.17 Bn 9.12 Bn 891.00 Mn 19.85 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 50.83 Bn
Dec 31, 2025 54.84 Bn
Sep 30, 2025 55.33 Bn
Jun 30, 2025 54.90 Bn
Mar 31, 2025 54.47 Bn
Dec 31, 2024 54.67 Bn
Sep 30, 2024 57.29 Bn
Jun 30, 2024 55.58 Bn
Mar 31, 2024 54.16 Bn
Dec 31, 2023 52.27 Bn
Sep 30, 2023 52.78 Bn
Jun 30, 2023 53.02 Bn
Mar 31, 2023 54.39 Bn
Dec 31, 2022 53.13 Bn
Sep 30, 2022 52.93 Bn
Jun 30, 2022 53.20 Bn
Mar 31, 2022 54.79 Bn
Dec 31, 2021 53.36 Bn
Sep 30, 2021 53.87 Bn
Jun 30, 2021 54.33 Bn